Xiaobin Wu - 23 Jun 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Reporting relationship: President and COO
Issuer ticker: ONC
Reported as of: 23 Jun 2026
Net transaction value: -$356,927
SEC form: 4
Accepted by SEC: 25 Jun 2026, 17:15:07 UTC
Prior SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Qing Nian, as Attorney-in-Fact

Key filing fact

Xiaobin Wu filed Form 4 for BeOne Medicines Ltd. (ONC) on 25 Jun 2026.

Key facts

This page summarizes Xiaobin Wu's Form 4 filing for BeOne Medicines Ltd. (ONC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Jun 2026, 17:15.

Change

Previous filing in this sequence was filed on 18 Jun 2026.
Current net transaction value: -$356,927.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001739452 Primary reporting owner

Wu Xiaobin

Relationship: President and COO
Address: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature: /s/ Qing Nian, as Attorney-in-Fact
Signature date: 25 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

American Depositary Shares

Sale

Transaction value: $356,927
Shares: -1,292
Change %: -100%
Price: $276.26
Shares after: 0
Date: 23 Jun 2026
Ownership: Direct
Footnotes: F1, F2, F3

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,273,724
Date: 23 Jun 2026
Ownership: Direct

ONC holding

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,365
Date: 23 Jun 2026
Ownership: Direct
Footnotes: F1

ONC holding

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,000
Date: 23 Jun 2026
Ownership: By Wife
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each American Depositary Share represents 13 Ordinary Shares.

Footnote F2

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.23 to $276.475, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.